| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC3114 |
| Trial ID | NCT05457010 |
| Disease | Acute Myeloid Leukemia | Myelodysplastic Syndrome |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SPRX002 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS |
| Year | 2022 |
| Country | United States |
| Company sponsor | Arcellx, Inc. |
| Other ID(s) | ARC-201 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||